Prostate Disease

Impact of COVID-19 pandemic on screening and diagnosis of patients with prostate cancer: a systematic review protocol
Seyed Mostafa Mostafavi Zadeh, Fatemeh Tajik, Yousef Moradi, Jafar Kiani, Roya Ghods, Zahra Madjd

BMJ Open Aug 2022, 12 (8) e063748; DOI: 10.1136/bmjopen-2022-063748
‘Is it painful’? A qualitative study on experiences of patients before prostate needle biopsy
Jinjiao Mao, Yun Dai, Lijuan Wang, Shucheng Pan, Wei Wang, Hongwei Yu

BMJ Open Sep 2022, 12 (9) e056619; DOI: 10.1136/bmjopen-2021-056619
PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer
Vy Tran, Anne Hong, Tom Sutherland, Kim Taubman, Su-Faye Lee, Daniel Lenaghan, Kapil Sethi, Niall M Corcoran, Nathan Lawrentschuk, H Woo, Lisa Tarlinton, Damien Bolton, Tim Spelman, Lauren Thomas, Russell Booth, Justin Hegarty, Elisa Perry, Lih-Ming Wong

BMJ Open Sep 2022, 12 (9) e061815; DOI: 10.1136/bmjopen-2022-061815
Stereotactic body radiotherapy (SBRT) versus androgen deprivation therapy (ADT) for oligometastatic prostate cancer: protocol for a prospective randomised control clinical trial
Xianzhi Zhao, Tao Wang, Yusheng Ye, Jing Li, Xu Gao, Huojun Zhang

BMJ Open Sep 2022, 12 (9) e051371; DOI: 10.1136/bmjopen-2021-051371
Association between immune-inflammatory indexes and lower urinary tract symptoms: an analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2005–2008)
Wen Liu, Jia Wang, Miaomiao Wang, Xin Ding, Miao Wang, Ming Liu

BMJ Open Mar 2024, 14 (3) e080826; DOI: 10.1136/bmjopen-2023-080826
Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy
Tara M Davidson, Nathan Foster, Fabrice Lucien, Svetomir Markovic, Haidong Dong, Jeffrey L Winters, Sean S Park, Jacob J Orme

BMJ Open May 2022, 12 (5) e050112; DOI: 10.1136/bmjopen-2021-050112
Organisation and delivery of supportive services for patients with prostate cancer in the National Health Service in England and Wales: a national cross-sectional hospital survey and latent class analysis
Joanna Dodkins, Adrian Cook, Melanie Morris, Julie Nossiter, Steve Prust, Steve Waller, Jan van der Meulen, Ajay Aggarwal, Noel Clarke, Heather Ann Payne

BMJ Open Nov 2023, 13 (11) e071674; DOI: 10.1136/bmjopen-2023-071674
Moving forward through consensus: a national Delphi approach to determine the top research priorities in prostate cancer in Uganda
Andrew Sentoogo Ssemata, Richard Muhumuza, Janet Seeley, Dorothy Chilambe Lombe, Monde Mwamba, Susan Msadabwe, Amos Deogratius Mwaka, Ajay Aggarwal

BMJ Open Nov 2023, 13 (11) e075739; DOI: 10.1136/bmjopen-2023-075739
Danish Prostate Cancer Consortium Study 1 (DPCC-1) protocol: Multicentre prospective validation of the urine-based three-microRNA biomarker model uCaP
Jacob Fredsøe, Eske Glud, Lars Boesen, Vibeke Løgager, Mads Hvid Poulsen, Bodil Ginnerup Pedersen, Michael Borre, Karina Dalsgaard Sørensen

BMJ Open Nov 2023, 13 (11) e077020; DOI: 10.1136/bmjopen-2023-077020
Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial
Hideaki Miyake, Yasumasa Kakei, Yuzo Nakano, Tomoaki Terakawa, Keiko Miyakoda, Kenichi Harada, Masato Fujisawa

BMJ Open Mar 2023, 13 (3) e070173; DOI: 10.1136/bmjopen-2022-070173

Main menu

Prostate Disease

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Prostate Disease

Pages